Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Towards a pharmacophore for amyloid.

Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, Sievers SA, Liu J, Barrio JR, Eisenberg D.

PLoS Biol. 2011 Jun;9(6):e1001080. doi: 10.1371/journal.pbio.1001080. Epub 2011 Jun 14.

2.

Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.

Meredith SC.

Ann N Y Acad Sci. 2005 Dec;1066:181-221. Review.

PMID:
16533927
3.

Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.

Nguyen P, Derreumaux P.

Acc Chem Res. 2014 Feb 18;47(2):603-11. doi: 10.1021/ar4002075. Epub 2013 Dec 24. Review.

PMID:
24368046
4.

Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.

Ramachandran G, Udgaonkar JB.

Biochemistry. 2013 Jun 18;52(24):4107-26. doi: 10.1021/bi400209z. Epub 2013 Jun 6. Review.

PMID:
23721410
5.

Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.

Margittai M, Langen R.

Q Rev Biophys. 2008 Aug-Nov;41(3-4):265-97. doi: 10.1017/S0033583508004733. Review.

PMID:
19079806
6.

A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.

Nath A, Rhoades E.

FEBS Lett. 2013 Apr 17;587(8):1096-105. doi: 10.1016/j.febslet.2013.02.044. Epub 2013 Mar 1. Review.

7.

Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding.

Inouye H, Kirschner DA.

Subcell Biochem. 2005;38:203-24. Review.

PMID:
15709480
8.

[Biochemistry of conformational transition and aggregation of amyloid proteins].

Yanagawa H, Ogawa Y.

Uirusu. 2001 Dec;51(2):163-70. Review. Japanese. No abstract available.

9.

Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.

Nerelius C, Fitzen M, Johansson J.

Biochem Biophys Res Commun. 2010 May 21;396(1):2-6. doi: 10.1016/j.bbrc.2010.02.105. Review.

PMID:
20494101
10.

Molecular structures of amyloid and prion fibrils: consensus versus controversy.

Tycko R, Wickner RB.

Acc Chem Res. 2013 Jul 16;46(7):1487-96. doi: 10.1021/ar300282r. Epub 2013 Jan 7. Review.

11.

Toward a molecular theory of early and late events in monomer to amyloid fibril formation.

Straub JE, Thirumalai D.

Annu Rev Phys Chem. 2011;62:437-63. doi: 10.1146/annurev-physchem-032210-103526. Review.

PMID:
21219143
12.

Recent structural and computational insights into conformational diseases.

Fernàndez-Busquets X, de Groot NS, Fernandez D, Ventura S.

Curr Med Chem. 2008;15(13):1336-49. Review.

PMID:
18537613
13.

Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.

Gorman PM, Chakrabartty A.

Biopolymers. 2001;60(5):381-94. Review.

PMID:
12115148
14.

Amyloid peptides and proteins in review.

Harrison RS, Sharpe PC, Singh Y, Fairlie DP.

Rev Physiol Biochem Pharmacol. 2007;159:1-77. Review.

PMID:
17846922
15.

Study of Protein Amyloid-Like Aggregates by Solid-State Circular Dichroism Spectroscopy.

Hu HY, Jiang LL, Hong JY.

Curr Protein Pept Sci. 2017;18(1):100-103. Review.

PMID:
27396751

Supplemental Content

Support Center